Prevention of Thrombosis in Percutaneous Coronary Angioplasty

  • M. A. J. Weber
  • J. Kotzur
  • A. Zitzmann
  • M. Haufe
  • W. Schramm
  • R. Lorenz
  • K. Theisen
Conference paper


Successful angioplasty includes prevention of thrombosis at the site of dilatation. The pathophysiology of thrombus formation after angioplasty resembles the process at the site of an advanced arteriosclerotic plaque.


Salicylic Acid Thrombus Formation Acetylsalicylic Acid Anti Platelet Therapy Aortocoronary Bypass 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Fuster, V., Steele, P., Chesebro JH (1985) Role of platelets and thrombosis in coronary atherosclerotic disease and sudden death. J Am Coll Cardiol 5: 175B - 184BPubMedCrossRefGoogle Scholar
  2. 2.
    Siess W, Roth P, Scherer B, Kurzmann J, Boehling B, Weber PC (1980) Platelet-membrane fatty acids, platelet aggregation, and thromboxane formation during a Macherel diet. Lancet 1: 441PubMedCrossRefGoogle Scholar
  3. 3.
    Lorenz, R, Spengler, U, Fischer, S, Duhm, J, Weber PC (1983) Platelet function, thromboxane formation and blood pressure control during supplementation of the western diet with cod liver oil. Circulation 67: 504–511PubMedCrossRefGoogle Scholar
  4. 4.
    Kromhout, D., Bosschiefer EB, Lezenne Coulander de C (1985) The inverse relation between fish consumption and 20-year mortality from coronary heart disease. N Engl J Med 312: 1205–1209PubMedCrossRefGoogle Scholar
  5. 5.
    Eichner ER (1984) Platelets carotids, and coronaries. Am J Med 77: 513–521PubMedCrossRefGoogle Scholar
  6. 6.
    Baumgartner HR (1984) Blutströmung and Thrombogenese Wechselwirkungen zwischen Blutplättchen, Gerinnungsfaktoren and Gefäßwand. Internist 25: 75–81PubMedGoogle Scholar
  7. 7.
    Mabin TA, Homes DR, Smith HC, Vlietstra RE, Bove AA, Reeder GS, Chesebro JH, Bresnahan JF, Orszulak TA (1985) Intracoronary thrombus: role in coronary occlusion complicating percutaneous transluminal coronary angioplasty. J Am Coll Cardiol 5: 198–202PubMedCrossRefGoogle Scholar
  8. 8.
    Lorenz R, Siess W, Weber PC (1981) Effects of very low dose versus standard acetylsalicylic acid, dipyridamile and sulfinpyrazone on platelet function and thromboxane formation for man. Eur J Pharmacol 70: 511–518PubMedCrossRefGoogle Scholar
  9. 9.
    Weber M, von Schacky C, Lorenz R, Meister W, Kotzur J, Reichart B, Theisen K, Weber PC (1984) Niedrig dosierte Acetylsalicylsäure (100 mg/tgl) nach aortokoronarer Bypassoperation. Klin Wochenschr 62: 458–464PubMedCrossRefGoogle Scholar
  10. 10.
    Lorenz RL, von Schacky C, Weber M, Meister W, Kotzur J, Reichart B, Theisen K, Weber PC (1984) Improved aortocoronary bypass patency by low-dose aspirin (100 mg daily). Effects on platelet aggregation and thromboxane formation. Lancet I: 1261–1264CrossRefGoogle Scholar
  11. 11.
    Hanson SR, Harker LA (1985) Effects of platelet-modifying drugs on arterial thromboembolism in baboons. J Clin Invest 75: 1591–1599PubMedCrossRefGoogle Scholar
  12. 12.
    Brown BG, Aillingham RA, Goede L, Wong M, Fee H, Roth J, Carey J (1981) Improved graft patency with antiplatelet drugs in patients treated for one year following coronary bypass surgery. Am J Cardiol 47: 494 (abstr)Google Scholar
  13. 13.
    The Persantine-Aspirin Reinfarction Study Research Group (1980) Persantine and aspirin in coronary heart disease. Circulation 62: 499–461Google Scholar
  14. 14.
    Telford AM, Wilson C (1981) Trial of heparin versus atenolol in prevention of myocardial infarction. Lancet I: 1225–1228CrossRefGoogle Scholar
  15. 15.
    Lewis HD, Davis JW, Archibald DG, Steinke WE, Smitherman TE, Doherty JE, Schnaper HW, LeWinter MM, Linares E, Pouget JM, Sabharwal SC, Chesler E, DeMots H (1983) Protective effects of aspirin against acute myocardial infarction and death in men with unstable angina. N Engl J Med 309: 396–403PubMedCrossRefGoogle Scholar
  16. 16.
    Preiss DU, Zobeley R (1983) Individuelle Heparin and Protamindosierung in der Herzchirurgie. Klin Wochenschr 61: 1141–1146PubMedCrossRefGoogle Scholar
  17. 17.
    Chesebro JH, Steele P, Lamb H, Stanson A, Holmes D, Dewanjee M, Badimon L, Fuster V (1984) Balloon angioplasty in pigs: effect of platelet-inhibitor drugs on platelet-thrombus deposition. Eur Heart J 5 [Suppl 1]: 70 (abstr)Google Scholar
  18. 18.
    Steele PM, Chesebro JH, Homes DR, Badimon L, Fuster V (1984) Balloon angioplasty in pigs: comparative effects of platelet-inhibitor drugs. Circulation 70 [Suppl II] 361 (abstr)Google Scholar
  19. 19.
    Swanson KT, Vlietstra RE, Holmes DR, Smith HC, Reeder GS, Bresnahan JF (1984) Efficacy of adjunctive dextran during percutaneous transluminal coronary angioplasty. Am J Cardiol 54: 447–448PubMedCrossRefGoogle Scholar
  20. 20.
    Weber MAJ, ASAAC Studiengruppe (1985) Aortokoronare Bypassoperation: Vergleich niedrig dosierter Actylsalicylsäure zu Antikoagulation. Z Kardiol 74 [Suppl. 5]: 38 (abstr)Google Scholar
  21. 21.
    Thornton MA, Grüntzig AR, Hollman J, King SB, Douglas JS (1984) Coumadin and aspirin in prevention of recurrence after transluminal coronary angioplasty: a randomized study. Circulation 69: 721–727PubMedCrossRefGoogle Scholar
  22. 22.
    Kaltenbach M (1984) Neue Technik zur steuerbaren Ballondilatation von Kranzgefäßverengungen. Z Kardiol 73: 669–673PubMedGoogle Scholar

Copyright information

© Dr. Dietrich Steinkopff Verlag GmbH & Co. KG, Darmstadt 1986

Authors and Affiliations

  • M. A. J. Weber
    • 1
    • 2
  • J. Kotzur
    • 1
  • A. Zitzmann
    • 1
  • M. Haufe
    • 1
  • W. Schramm
    • 1
  • R. Lorenz
    • 1
  • K. Theisen
    • 1
  1. 1.Medizinische Klinik ImmenstadtUniversity of MunichGermany
  2. 2.II. Med. AbteilungStädt. Krankenhaus München-NeuperlachMünchen 83West Germany

Personalised recommendations